Monday, May 4, 2015
- 5:30pm-6:30pm
-
Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records
Poster Session C: Immunosuppression/Compliance • Exhibit Hall E
- 5:30pm-6:30pm
-
Bidirectional Regulation and IL35 Surface Expression By Treg Cells
Poster Session C: Late Breaking • Exhibit Hall E
- 5:30pm-6:30pm
-
Biomarker for Calcineurin Inhibitors Nephrotoxicity in Solid Organ Transplantation: Validation of a Urine Gene Expression Panel
Poster Session C: Translational Biomarkers and Immune Monitoring • Exhibit Hall E
- 5:30pm-6:30pm
-
Biomarker Panel Profile for Identification of High-Risk Patients After Heart Transplantation
Poster Session C: Translational Biomarkers and Immune Monitoring • Exhibit Hall E
- 5:30pm-6:30pm
-
Biopsychronology: Live Confocal Imaging of Biopsies to Assess Organ Function
Poster Session C: Translational Biomarkers and Immune Monitoring • Exhibit Hall E
- 5:30pm-6:30pm
-
Birth Weight as a Marker of Nephron Mass: Impact on Renal Allograft Function
Poster Session C: Living Donor Issues 2 • Exhibit Hall E
- 5:30pm-6:30pm
-
Birth Weight as a Marker of Nephron Mass: Predicting Living Kidney Donor Outcomes
Poster Session C: Living Donor Issues 2 • Exhibit Hall E
- 5:30pm-6:30pm
-
Blocking CD40/CD154 Co-Stimulation Prevents Acute Antibody-Mediated Renal Allograft Rejection Induced by Memory CD4 T Cells
- 5:30pm-6:30pm
-
Blood Gene Expression at 3 Months Post-Transplantation Predicts 1-Year Histological Features in Renal Transplantation
Poster Session C: Translational Biomarkers and Immune Monitoring • Exhibit Hall E
- 5:30pm-6:30pm
-
Can We Use MDRD or CKD-EPI Equation for Donor Selection?
Poster Session C: Living Donor Issues 2 • Exhibit Hall E
- «Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 48
- Next Page»